Authors:
NASLUND E
BACKMAN L
HOLST JJ
THEODORSSON E
HELLSTROM PM
Citation: E. Naslund et al., IMPORTANCE OF SMALL-BOWEL PEPTIDES FOR THE IMPROVED GLUCOSE-METABOLISM 20 YEARS AFTER JEJUNOILEAL BYPASS FOR OBESITY, Obesity surgery, 8(3), 1998, pp. 253-260
Authors:
WILLMS B
IDOWU K
HOLST JJ
CREUTZFELDT W
NAUCK MA
Citation: B. Willms et al., OVERNIGHT GLP-1 NORMALIZES FASTING BUT NOT DAYTIME PLASMA-GLUCOSE LEVELS IN NIDDM PATIENTS, EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 106(2), 1998, pp. 103-107
Authors:
RASMUSSEN TN
BERSANI M
SCHMIDT P
THIM L
KOFOD H
JORGENSEN PN
POULSEN SS
HOLST JJ
Citation: Tn. Rasmussen et al., ISOLATION AND MOLECULAR CHARACTERIZATION OF PORCINE CALCITONIN-GENE-RELATED PEPTIDE (CGRP) AND ITS ENDOCRINE EFFECTS IN THE PORCINE PANCREAS, Pancreas, 16(2), 1998, pp. 195-204
Citation: J. Svartberg et al., THE ETHANOL AUGMENTATION OF GLUCOSE-INDUCED INSULIN-SECRETION IS ABOLISHED BY CALCIUM ANTAGONISM WITH NIFEDIPINE - NO EVIDENCE FOR A ROLE OF GLUCAGON-LIKE PEPTIDE-1 (GLP-1), Pancreas, 16(1), 1998, pp. 66-71
Authors:
SEIFARTH C
BERGMANN J
HOLST JJ
RITZEL R
SCHMIEGEL W
NAUCK MA
Citation: C. Seifarth et al., PROLONGED AND ENHANCED SECRETION OF GLUCAGON-LIKE PEPTIDE-1 (7-36 AMIDE) AFTER ORAL SUCROSE DUE TO ALPHA-GLUCOSIDASE INHIBITION (ACARBOSE) IN TYPE-2 DIABETIC-PATIENTS, Diabetic medicine, 15(6), 1998, pp. 485-491
Authors:
NAUCK MA
WEBER I
BACH I
RICHTER S
ORSKOV C
HOLST JJ
SCHMIEGEL W
Citation: Ma. Nauck et al., NORMALIZATION OF FASTING GLYCEMIA BY INTRAVENOUS GLP-1 ([7-36 AMIDE] OR [7-37]) IN TYPE-2 DIABETIC-PATIENTS, Diabetic medicine, 15(11), 1998, pp. 937-945
Citation: A. Wettergren et al., THE INHIBITORY EFFECT OF GLUCAGON-LIKE PEPTIDE-1 (7-36)AMIDE ON ANTRAL MOTILITY IS ANTAGONIZED BY ITS N-TERMINALLY TRUNCATED PRIMARY METABOLITE GLP-1 (9-36)AMIDE, Peptides (New York, N.Y. 1980), 19(5), 1998, pp. 877-882
Citation: A. Wettergren et al., GLUCAGON-LIKE PEPTIDE-1 INHIBITS GASTROPANCREATIC FUNCTION BY INHIBITING CENTRAL PARASYMPATHETIC OUTFLOW, American journal of physiology: Gastrointestinal and liver physiology, 38(5), 1998, pp. 984-992
Authors:
WETTERGREN A
PRIDAL L
WOJDEMANN M
HOLST JJ
Citation: A. Wettergren et al., AMIDATED AND NON-AMIDATED GLUCAGON-LIKE PEPTIDE-1 (GLP-1) - NONPANCREATIC EFFECTS (CEPHALIC PHASE ACID-SECRETION) AND STABILITY IN PLASMA IN HUMANS, Regulatory peptides, 77(1-3), 1998, pp. 83-87
Authors:
NASLUND E
GRYBACK P
BACKMAN L
JACOBSSON H
HOLST JJ
THEODORSSON E
HELLSTROM PM
Citation: E. Naslund et al., DISTAL SMALL-BOWEL HORMONES - CORRELATION WITH FASTING ANTRODUODENAL MOTILITY AND GASTRIC-EMPTYING, Digestive diseases and sciences, 43(5), 1998, pp. 945-952
Authors:
WOJDEMANN M
WETTERGREN A
STERNBY B
HOLST JJ
LARSEN S
REHFELD JF
OLSEN O
Citation: M. Wojdemann et al., INHIBITION OF HUMAN GASTRIC LIPASE SECRETION BY GLUCAGON-LIKE PEPTIDE-1, Digestive diseases and sciences, 43(4), 1998, pp. 799-805
Authors:
TOLESSA T
GUTNIAK M
HOLST JJ
EFENDIC S
HELLSTROM PM
Citation: T. Tolessa et al., GLUCAGON-LIKE PEPTIDE-1 RETARDS GASTRIC-EMPTYING AND SMALL-BOWEL TRANSIT IN THE RAT - EFFECT MEDIATED THROUGH CENTRAL OR ENTERIC NERVOUS MECHANISMS, Digestive diseases and sciences, 43(10), 1998, pp. 2284-2290
Authors:
NAUCK MA
SAUERWALD A
RITZEL R
HOLST JJ
SCHMIEGEL W
Citation: Ma. Nauck et al., INFLUENCE OF GLUCAGON-LIKE PEPTIDE 1 ON FASTING GLYCEMIA IN TYPE-2 DIABETIC-PATIENTS TREATED WITH INSULIN AFTER SULFONYLUREA SECONDARY FAILURE, Diabetes care, 21(11), 1998, pp. 1925-1931
Citation: J. Gromada et al., CELLULAR-REGULATION OF ISLET HORMONE-SECRETION BY THE INCRETIN HORMONE GLUCAGON-LIKE PEPTIDE-1, Pflugers Archiv, 435(5), 1998, pp. 583-594
Authors:
TOLESSA T
GUTNIAK M
HOLST JJ
EFENDIC S
HELLSTROM PM
Citation: T. Tolessa et al., INHIBITORY EFFECT OF GLUCAGON-LIKE PEPTIDE-1 ON SMALL-BOWEL MOTILITY - FASTING BUT NOT FED MOTILITY INHIBITED VIA NITRIC-OXIDE INDEPENDENTLY OF INSULIN AND SOMATOSTATIN, The Journal of clinical investigation, 102(4), 1998, pp. 764-774
Citation: A. Flint et al., GLUCAGON-LIKE PEPTIDE-1 PROMOTES SATIETY AND SUPPRESSES ENERGY-INTAKEIN HUMANS, The Journal of clinical investigation, 101(3), 1998, pp. 515-520
Authors:
JENSEN PB
BLUME N
MIKKELSEN JD
LARSEN PJ
JENSEN HI
HOLST JJ
MADSEN OD
Citation: Pb. Jensen et al., TRANSPLANTABLE RAT GLUCAGONOMAS CAUSE ACUTE ONSET OF SEVERE ANOREXIA AND ADIPSIA DESPITE HIGHLY ELEVATED NPY MESSENGER-RNA LEVELS IN THE HYPOTHALAMIC ARCUATE NUCLEUS, The Journal of clinical investigation, 101(2), 1998, pp. 503-510
Authors:
NASLUND E
SKOGAR S
GRYBACK P
JACOBSSON H
HOLST JJ
HELLSTROM PM
Citation: E. Naslund et al., GLUCAGON-LIKE PEPTIDE-1 (GLP-1) IS A POWERFUL INHIBITOR OF GASTRIC-EMPTYING IN MAN, Gastroenterology, 114(4), 1998, pp. 3329-3329
Authors:
DEACON CF
KNUDSEN LB
MADSEN K
WIBERG FC
JACOBSEN O
HOLST JJ
Citation: Cf. Deacon et al., DIPEPTIDYL PEPTIDASE-IV RESISTANT ANALOGS OF GLUCAGON-LIKE PEPTIDE-1 WHICH HAVE EXTENDED METABOLIC STABILITY AND IMPROVED BIOLOGICAL-ACTIVITY, Diabetologia, 41(3), 1998, pp. 271-278
Citation: M. Toftnielsen et al., EXAGGERATED SECRETION OF GLUCAGON-LIKE PEPTIDE-1 (GLP-1) COULD CAUSE REACTIVE HYPOGLYCEMIA, Diabetologia, 41(10), 1998, pp. 1180-1186
Authors:
ALMIND K
AMBYE L
URHAMMER SA
HANSEN T
ECHWALD SM
HOLST JJ
GROMADA J
THORENS B
PEDERSEN O
Citation: K. Almind et al., DISCOVERY OF AMINO-ACID VARIANTS IN THE HUMAN GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE (GIP) RECEPTOR - THE IMPACT ON THE PANCREATIC BETA-CELL RESPONSES AND FUNCTIONAL EXPRESSION STUDIES IN CHINESE-HAMSTERFIBROBLAST CELLS, Diabetologia, 41(10), 1998, pp. 1194-1198
Authors:
DEACON CF
RIBEL U
ROED B
HOLM HBJ
HOLST JJ
CARR RD
Citation: Cf. Deacon et al., GLUCAGON-LIKE PEPTIDE-1 (9-36)AMIDE DOES NOT DESENSITIZE CONSCIOUS PIGS TO THE ANTI-HYPERGLYCEMIC ACTION OF GLP-1, Diabetologia, 41, 1998, pp. 72-72
Citation: M. Toftnielsen et al., CONTINUOUS SUBCUTANEOUS INFUSION OF GLP-1 LOWERS BLOOD-GLUCOSE AND REDUCES APPETITE IN NIDDM PATIENTS, Diabetologia, 41, 1998, pp. 234-234